Marc D. Kozin

Marc D. Kozin

Board Member at UFP Technologies, Inc.

Are you Marc D. Kozin? Claim your profile
 
  • IDENTIFY executive and board member connections in Marc D. Kozin's network.
  • FOLLOW changes in Marc D. Kozin's employment.
  • CONNECT with Marc D. Kozin through your network of contacts.

Marc D. Kozin's Executive Work History


Current
Board Member,
Board Member
Equilar on 06/22/2022
Vascular Biogenics Ltd.
Board Member,
Board Member
UFP Technologies, Inc. DEF 14A on 04/29/2022
UFP Technologies, Inc.
Advisor,
Advisor
Equilar on 01/10/2022
HealthCare Royalty Partners
Past
To view Marc D. Kozin's complete executive work history,
Age
60
 

Marc D. Kozin's Biography


Marc Kozin joined our board of directors in November 2020 as vice chairman and was appointed to chairman in July 2021. Mr. Kozin has three decades of industry expertise advising biopharmaceutical, life sciences and medtech companies. He is currently the chairman of the strategy advisory board of HealthCare Royalty Partners (HCR), a leading investment firm in healthcare, providing royalty monetization and senior debt, a position he has held since 2013. Previously, Mr. Kozin was a career strategy consultant, having served as president of L.E.K. Consulting’s North American practice from 1997 to 2012 and as senior advisor from 2012 to 2018. He began his career at L.E.K. in 1987 by helping establish the Boston office and led the development of L.E.K.’s industry-leading life science strategic planning practice. Mr. Kozin has served on more than a dozen boards in a variety of roles and on all committees. He serves as director and serves on the compensation committee of UFP Technologies (Nasdaq: UFPT). Previously, he served as director for Dicerna Pharmaceuticals (Nasdaq: DRNA), prior to its acquisition by Novo Nordisk. He also served on the board of Endocyte (Nasdaq: ECYT) which was acquired by Novartis in 2018, and was also a board member of Dyax (Nasdaq: DYAX), which was acquired by Shire Plc in 2015. He also served on the boards of directors of Brandwise, Inc., Lynx Therapeutics, Inc., Assurance Medical, Inc., Medical Simulation Corporation, Advizex, and CrunchTime! Information Systems. Mr. Kozin has served as director of The Greenlight Fund, a non-profit focused on improving the lives of inner city children in families, since 2017. He was also on the board of governors at New England Medical Center and the board of DukeEngage for several years. Mr. Kozin received a B.S. degree in economics from Duke University in Durham, N.C. and a M.B.A. in finance from The Wharton School of the University of Pennsylvania in Philadelphia.

Source: Vascular Biogenics Ltd. on 06/22/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Marc D. Kozin. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Marc D. Kozin's network.
  • FOLLOW changes in Marc D. Kozin's employment.
  • CONNECT with Marc D. Kozin through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Marc D. Kozin

Marc D. Kozin's Connections (152)


Timothy J. Barberich
Vice Chairman, Frequency Therapeutics, Inc.
Thomas W. Oberdorf
Chairman and Chief Executive Officer, SIRVA, Inc.
Christophe Couturier
EVP, AMEA, Avantor, Inc.
Mary M. Fisher
Chairman of the Board and Chief Executive Officer, Colorescience Inc
Vipul Patel M.D.
Board Member, Isleworth Healthcare Acquisition Corp.
Philip S. Low Ph.D.
Chief Scientific Officer, On Target Laboratories
Christopher A. Kroeger M.D.
Chief Executive Officer, Founder, and Director, MapLight Therapeutics
Ralf H. Rosskamp M.D.
Former Chief Medical Officer, Dicerna Pharmaceuticals, Inc.
Robert D. Ciappenelli
Chief Strategy Officer, Dicerna Pharmaceuticals, Inc.
Regina M. Paglia
Former Senior Vice President, Human Resources, Paratek Pharmaceuticals, Inc.